The regulation of HGF and TGF- by an angiotensin II type 1 receptor antagonist in hepatic ischemia-reperfusion injury

By Araya J.   Tsuruma T.   Hirata K.   Yagihashi A.   Meguro M.   Kawakami M.   Yanai Y.   Watanabe N.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite

Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor

By Dragun D.   Brasen J.H.   Schonemann C.   Fritsche L.   Budde K.   Neumayer H.-H.   Luft F.C.   Wallukat G.  

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2104-2105

Elsevier

Access to resources Recommend Favorite

Angiotensin II type 1 receptor blockade after cardiac transplantation reduced the incidence and severity of transplant vasculopathy in an animal-based study

By Richter M.H.C.   Richter H.   Barten M.   Schramm D.   Gummert J.   Mohr F.W.   Skupin M.   Olbrich H.G.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1484-1485

Elsevier

Access to resources Recommend Favorite

Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T h 1 and T h 2 cells

By Anderson Per  

International Immunology, Vol. 15, Iss. 11, 2003-11 ,pp. : 1309-1317

Oxford University Press

Access to resources Recommend Favorite

Potential Utility of Telmisartan, an Angiotensin II Type 1 Receptor Blocker with Peroxisome Proliferator-Activated Receptor-&ggr; (PPAR-&ggr;)-Modulating Activity for the Treatment of Cardiometabolic Disorders

By  

Current Molecular Medicine, Vol. 7, Iss. 5, 2007-08 ,pp. : 463-469

Bentham Science Publishers

Access to resources Recommend Favorite